Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+1.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Share-based Compensation Growth (1y) (2016 - 2022)

Analysis

Immuron (IMRN) Share-based Compensation Growth (1y) (2016 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn 19.90%
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn 2.67%
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn 71.86%
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn -3.46%
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn -7.69%
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn -22.43%
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn 3.34%
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn -
10 Immuron 7.25 Mn -1.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 78.28%
Dec 31, 2021 97.23%
Dec 31, 2020 -354.81%
Jun 30, 2017 2,924.77%
Jun 30, 2016 -58.43%
API Access

Immuron Share-based Compensation Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-growth-1y&ticker=IMRN&period=max&api_key=YOUR_API_KEY